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We have assembled, annotated, and analyzed a
database of over 1700 breakpoints from the most
common chromosomal rearrangements in human
leukemias and lymphomas. Using this database, we
show that although the CpG dinucleotide constitutes
only 1% of the human genome, it accounts for 40%–
70% of breakpoints at pro-B/pre-B stage transloca-
tion regions—specifically, those near the bcl-2, bcl-1,
and E2A genes. We do not observe CpG hotspots
in rearrangements involving lymphoid-myeloid pro-
genitors, mature B cells, or T cells. The stage speci-
ficity, lineage specificity, CpG targeting, and unique
breakpoint distributions at these cluster regions
may be explained by a lesion-specific double-strand
breakage mechanism involving the RAG complex
acting at AID-deaminated methyl-CpGs.
INTRODUCTION
Chromosomal rearrangements arise when DNA double-strand
breaks (DSBs) occur at two separate regions of the genome
and the resultant DNA ends are aberrantly joined into a new con-
figuration. Pathologic rearrangements are especially frequent in
human lymphomas and leukemias, and the most common are
the bcl-2 and bcl-1 translocations. However, the molecular
mechanisms underlying the DSBs at the bcl-2 and bcl-1 regions
are unknown.
Three main types of DSB mechanisms have been identified in
human lymphoid malignancies: (1) V(D)J type, in which the RAG
endonuclease creates a site-specific DSB 50 of a recombination
signal sequence (RSS) with a consensus of CACAGTG (12 or 23
spacer) ACAAAAACC in early B or T cells (Bassing et al., 2002;
Dudley et al., 2005; Schatz, 2004; Schlissel et al., 2006; Tone-
gawa, 1983); (2) class-switch recombination (CSR) type, in which
activation-induced cytidine deaminase (AICDA or AID) deami-1130 Cell 135, 1130–1142, December 12, 2008 ª2008 Elsevier Inc.nates cytidines on the single-stranded portions of kilobases-
long R loops at immunoglobulin (Ig) switch regions, leading to
DSBs in activated B cells (Di Noia and Neuberger, 2007; Ramiro
et al., 2004; Unniraman and Schatz, 2006); and (3) random-type
breakage, presumed to be due to sequence-independent mech-
anisms such as reactive oxygen species (ROS) or ionizing radia-
tion that generate DSBs randomly throughout the genome
(Greaves and Wiemels, 2003; Lieber et al., 2006).
As we and others have shown, DSBs at the bcl-2 and bcl-1 loci
do not fit into any of these three mechanisms (Jaeger et al., 2000;
Marculescu et al., 2002; Raghavan et al., 2004; Welzel et al.,
2001). Rather, breakpoint sequence analysis reveals that DSBs
at the bcl-2 and bcl-1 regions, and additionally a third gene,
E2A, fall into a fourth type of DSB mechanism, CpG type, marked
by a high degree of focusing to the dinucleotide sequence, CpG,
and occurrence only in the pro-B/pre-B stage. We propose
a mechanism of translocations at methyl-CpG sequences in
early B cells attributable to the sequential action of AID and the
RAG complex.
RESULTS
Overview of bcl-2, bcl-1, and E2A Chromosomal
Breakpoint Distributions
Human lymphoid malignancies are predominantly B cell in origin,
and many involve chromosomal translocations between one site
and the Ig loci or between two non-Ig loci (Figure 1). Though the
DSBs at the Ig loci are well-characterized, the cause of the DSBs
at non-Ig loci, such as bcl-2, bcl-1, and E2A, are poorly under-
stood.
The first clue for determining how a DSB occurred is its precise
location. Free DNA ends are often degraded prior to joining; thus,
the position of the initial DSB, before degradation, can be difficult
to determine. The closest approximation is the breakpoint, or ex-
act position where the rearranged allele ceases to match the nor-
mal alleles. Analysis of 695 human translocation breakpoints at
bcl-2, bcl-1, and E2A revealed a distinctive pattern of clustering
around CpGs (Table 1, Figure 2, and Table S1 and Figures S1–S3
available online). Breakpoints at CpGs account for 43% of
events at bcl-2, 35% of events at bcl-1, and 53% of events at
E2A (Figure 2, Figure S3). These frequencies are dramatically
higher than the 6% frequency one would expect if breakpoints
occurred randomly throughout the breakpoint region (Table S1,
Figure S3) and may be underestimates of the true frequency oc-
curring at CpGs. Because of DNA end degradation prior to join-
Figure 1. Diagrams of the bcl-2, bcl-1, and E2A Translocations
(A) In the bcl-2 translocation, a break arises downstream of the coding portion
of the bcl-2 gene on chromosome 18. The side of the break closest to the bcl-2
gene (telomeric side) joins to JH segments of the IgH locus on chromosome 14.
The centromeric side of the bcl-2 locus usually joins to a DH segment. See Fig-
ure 2 and Figure S1 for description of the MBR, mcr, and icr breakpoint cluster
regions downstream of the bcl-2 coding region.
(B) In the bcl-1 translocation, a break at the MTC arises 110 kb centromeric of
the bcl-1 gene (cyclin D1). The telomeric portion of the break joins to one of the
JH segments at IgH. The centromeric portion usually joins to a DH segment.
(C) In the t(1;19) translocation, the indicated portions are exchanged.
In all diagrams, the centromere is located on the same side as the chromo-
some label. The exon numbers are in boxes.ing, breakpoints close to, but not directly at, CpGs may have
originated from CpG positions (Figure S3).
CpGs in the bcl-2 MBR, icr, and mcr Are Hotspots
for Translocation Breakpoints
Within the bcl-2 region, breakpoints are highly concentrated at
three small clusters. Fifty percent occur in the major breakpoint
region (MBR), 13% in the intermediate cluster region (icr) about
18 kb centromeric to the MBR, and 5% in the minor cluster re-
gion (mcr) about 11 kb centromeric to the icr (Figure S1A) (Wein-
berg et al., 2007).
Of the bcl-2 translocations sequenced, 88% occur in the
175 bp MBR, which itself contains three breakpoint peaks
(Figure 2A). Strikingly, CpGs are found at the highest spikes of
all three peaks. Of 487 breakpoints in the MBR, 208 (43%) occur
precisely at one of the five CpG sites in the region (p < 1095). The
average MBR breakpoint is 4.4 bp from the nearest CpG, com-
pared to 11.2 bp if the breakpoints were randomly distributed
(p < 1041) (Table S1).
At the 105 bp icr, eight of the 11 sequenced breakpoints occur
at one of the two CpGs (p < 107), and the remainder are less
than 6 bp away from a CpG (Figure 2B). In contrast, none are ob-
served in the 75 bp region between the two CpGs. Overall, the
average distance of these 11 breakpoints from a CpG site is
0.8 bp, versus 22 bp if they were randomly distributed (p <
106) (Table S1).
The 561 bp mcr contains six CpGs, spaced widely apart
(Figure 2C). Again, breakpoints are located very close to CpGs,
while intervening regions are devoid of breakpoints (Figure 2C).
Of the 19 sequenced breakpoints, 14 are located directly at
CpGs (p < 1017). The average distance between a breakpoint
and a CpG site is 0.6 bp, in contrast to 40 bp if these breakpoints
were randomly distributed (p < 1012) (Table S1).
In addition to the breakpoints located in the three cluster re-
gions described above, 27 sequenced bcl-2 breakpoints are lo-
cated between these three cluster regions. Of these, 13 (48%)
are located less than 10 bp away from a CpG, including 5
(19%) directly at CpGs (p = 0.002) (Table S1).
These findings strongly suggest that CpG is a DSB hotspot in
the MBR, icr, and mcr clusters of bcl-2. Statistical analysis with
the binomial distribution, Student’s t test, and Mann-Whitney U
test indicates that the proximity of these breakpoints to CpGs
is highly significant (Table S1).
CpGs in the bcl-1 MTC Are Hotspots for Translocation
Breakpoints
In mantle cell lymphomas, 30% of translocations occur within
the 150 bp major translocation cluster (MTC) (Bertoni et al.,
2004), which contains seven CpGs (Figures S1B and S2). The
MTC contains 104 of the 114 bcl-1 translocation breakpoints se-
quenced, 38 (37%) of which occur at CpGs (p < 108). MTC
breakpoints average 2.5 bp from CpGs, compared to 7.8 bp if
breakpoints were distributed randomly over the 150 bp region
(p < 1011). Notably, the ten breakpoints outside the MTC aver-
age 8.8 bp from CpGs, in contrast to 45.3 bp if randomly distrib-
uted (p = 0.0009) (Table S1). Hence, CpGs appear to be DSB
hotspots in the MTC as well (Figure 3).Cell 135, 1130–1142, December 12, 2008 ª2008 Elsevier Inc. 1131
Table 1. Summary of Translocation Breakpoint Features
Name Clinical Entity Rearrangement
Number of
Breakpoints
Stage of
Rearrangement Breakage Types
bcl-2 FL and DLBL t(14;18)(q32;q21) 551 pro-B/pre-B CpG, V(D)J
bcl-1 MCL t(11;14)(q13;q32) 114 pro-B/pre-B CpG, V(D)J
E2A-PBX1 pre-B/B ALL t(1;19)(q23;p13) 30 pro-B/pre-B CpG, random
TEL-AML1 pre-B/B ALL t(12;21)(p12;q22) 53 LM HSC random
MLL primary ALL t(4;11)(q21;q23) 254 LM HSC random
MLL primary ALL t(9;11)(p22;q23) 17 LM HSC random
MLL primary ALL other 20 LM HSC random
MLL primary AML t(4;11)(q21;q23) 11 LM HSC random
MLL primary AML t(9;11)(p22;q23) 6 LM HSC random
MLL primary AML other 7 LM HSC random
MLL therapy-related
ALL and AML
t(4;11)(q21;q23) 5 LM HSC random, topoisomerase
II-related
MLL therapy-related
ALL and AML
t(9;11)(p22;q23) 12 LM HSC random, topoisomerase
II-related
MLL therapy-related
ALL and AML
t(11;16)(q23;p13) 11 LM HSC random, topoisomerase
II-related
MLL therapy-related
ALL and AML
other 7 LM HSC random, topoisomerase
II-related
AML1-ETO AML t(8;21)(q22;q22) 133 LM HSC random
BCR-ABL CML t(9;22)(q34;q11) 35 LM HSC random
c-myc sporadic BL t(8;14)(q24;q32) 125 activated B CSR, random
bcl-6 mature B lymphomas t(3;14)(q27;q32) 38 activated B CSR, random
SCL-SIL pre-T/T ALL del(1)(p32) 209 pro-T/pre-T V(D)J
p16 deletion pre-T/T ALL del(9)(p21) 26 pro-T/pre-T V(D)J
p16 deletion T-CLL del(9)(p21) 2 pro-T/pre-T V(D)J
p16 deletion pre-B/B ALL del(9)(p21) 13 pro-T/pre-T V(D)J
SCL pre-T/T ALL t(1;14)(p32;q11) 14 pro-T/pre-T V(D)J, random
SCL pre-T/T ALL t(1;7)(p32;q34) 2 pro-T/pre-T V(D)J, random
SCL pre-T/T ALL t(1;3)(p32;q21) 2 pro-T/pre-T V(D)J, random
SCL pre-B/B ALL t(1;14)(p32;q11) 1 pro-T/pre-T V(D)J, random
LMO2 pre-T/T ALL t(11;14)(p13;q11) 27 pro-T/pre-T V(D)J, random
LMO2 pre-T/T ALL t(7;11)(q34;p13) 2 pro-T/pre-T V(D)J, random
LMO2 pre-T/T ALL del(11)(p12p13) 2 pro-T/pre-T V(D)J, random
HOX11 pre-T/T ALL t(10;14)(q24;q11) 13 pro-T/pre-T V(D)J
TTG1 pre-T/T ALL t(11;14)(p15;q11) 6 pro-T/pre-T V(D)J
Total 1748
Numbers of breakpoints are listed for rearrangements and clinical entities analyzed in the text, followed by estimated stage during which the rearrange-
ment occurs and the apparent types of breakage involved at one or both chromosomes. For example, bcl-2 translocations tend to involve a CpG-type
double-strand break (DSB) on chromosome 18 and a V(D)J-type DSB on chromosome 14. Random-type breakage does not appear attached to a spe-
cific motif, is more regional in nature, and is presumed to be due to ionizing radiation, reactive oxygen species, or some other relatively sequence-in-
dependent mechanism. Abbreviations are as follows: FL, follicular lymphoma; DLBL, diffuse large B cell lymphoma; MCL, mantle cell lymphoma; ALL,
acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myelogenous leukemia; BL, Burkitt lymphoma; CLL, chronic lymphocytic
leukemia; LM HSC, lymphoid-myeloid hematopoietic stem cell; and CSR, class switch recombination.CpGs in the E2A Cluster Are Hotspots for Translocation
Breakpoints
Most of the breakpoints atE2Aoccur within a 23 bp zone contain-
ing two CpGs (Wiemels et al., 2002) (Figure S1). Fifteen of the 24
sequenced breakpoints occur at CpGs (p = 0.0001), averaging
1.1 bp to the closest CpG, versus 3.3 bp if they were randomly1132 Cell 135, 1130–1142, December 12, 2008 ª2008 Elsevier Inc.distributed in the 23 bp region (p = 0.0005). Interestingly, the cor-
responding breakpoints on PBX1 do not have a tendency to oc-
cur at or close to CpGs (p > 0.9) and have only a slight tendency
toward CAC (p = 0.05) [the minimal V(D)J recombination motif],
though not directly at CAC (p > 0.1) (Table S1). Therefore, CpGs
appear to be DSB hotspots in the E2A cluster but not in PBX1.
Figure 2. Sequence-Level Breakpoint Diagrams for bcl-2 Clusters and SCL-SIL
Breakpoint distributions are plotted for the bcl-2 MBR (A), bcl-2 icr (B), and bcl-2 mcr (C). Each breakpoint is represented as a triangle adjoining the breakpoint
site, with the top strand sequences running telomeric to centromeric, der(14) breakpoints above, and der(18) breakpoints below. Breakpoint distributions for the
main SCL (D), and SIL (E) breakpoint clusters are shown, with the top strand sequences running telomeric to centromeric, with telomeric breakpoints above and
centromeric breakpoints below. Note the different shapes of the distributions in (A) versus (D) and (E). Breakpoints in the bcl-2 MBR fall into bell-shaped distri-
butions, with peaks at CpGs and a decline of breakpoints on both sides. Breakpoints at the main SCL and SIL peaks are spiked at CAC and tail off only in the
direction 50 of the CAC. This implies that different mechanism(s) operate at the MBR versus SCL and SIL.CpG Is the Most Significant Dinucleotide Motif at bcl-2,
bcl-1, and E2A and Is More Significant than CAC
To confirm our observation, we examined breakpoint proximity
to all the other dinucleotide motifs, to A, C, G, T, W, and S,
and to ;CAC / GTG; (Table S1 and Supplemental Experimental
Procedures). Although certain motifs have lower average dis-
tances than CpG (e.g., the mononucleotide motif S [C or G, of
which CpG is a subset]), they are not statistically significant. Cer-
tain motifs score significantly because they happen to occur next
to CpGs, but not nearly to the same level as CpG, and these
never extend to other translocations or clusters. Among the
bcl-2 MBR, bcl-2 icr, bcl-2 mcr, bcl-1 MTC, and E2A breakpointclusters, and to a lesser degree the unclustered breakpoints (the
ones at the bcl-2, bcl-1, or E2A gene loci, but not within the pre-
ferred breakpoint zones), CpG is consistently the most signifi-
cant motif in three different statistical tests.
Initial Chromosomal Breakage Likely Occurs Directly
at or near CpGs
Examination of both derivatives of a reciprocal translocation
helps localize, more precisely, the position of the originating
DSB (Figures S4A and S4B). This is because the two breakpoints
define a window within which initial breakage likely occurred. This
information is only available for a subset of the translocationsCell 135, 1130–1142, December 12, 2008 ª2008 Elsevier Inc. 1133
analyzed above: 46 cases from bcl-2, 23 from bcl-1, and six from
E2A (Figure S2). Of these, 32 (70%) from bcl-2, 15 (65%) from
bcl-1, and four (67%) from E2A have one or both breakpoints at
CpGs. Significantly, one case from bcl-1 and nine cases from
bcl-2, including one case from the bcl-2 mcr, exhibit a breakage
window of zero. All ten were at CpGs, strongly suggesting that the
precise position of the initial DSB was at a CpG.
Staging of Translocations from Lymphomas
and Leukemias
In order to elucidate the mechanism behind CpG-type transloca-
tions, we sought to determine the developmental stage(s) in
which they occur. An overview of the major recurrent rearrange-
ments in myeloid and lymphoid tumors is provided in the Supple-
mental Introduction, and the results of our and others’ analyses
are shown in Figure 4.
Staging translocations is not obvious because tumors can be
at one stage of development but contain translocations from prior
stages (Figures 4B and 4C). For instance, bcl-2, bcl-1, c-myc, and
bcl-6 translocations are all found in mature B cell lymphomas.
However, we know that bcl-2 and bcl-1 translocations occur at
the preceding pro-B stage because they join to IgH RSSs, char-
acteristic of V(D)J recombination, which occurs during the pro-B
stage. On the other hand, c-myc and bcl-6 translocations occur
at the mature/activated B cell stage, as they involve the IgH
switch regions, characteristic of CSR, which occurs during the
activated B cell stage. Similarly, LMO2, HOX11, TTG1, and SCL
translocate with TCR RSSs during the pro-T or pre-T stage. But
for translocations where neither of the DSBs can be assigned
to a stage of development, additional information is required.
Figure 3. Frequencies of Breakpoints at CpG in Various Chromo-
somal Rearrangements
Percentages of breakpoints at CpGs are plotted for various chromosomal re-
arrangements, organized by cell lineage and stage of development when the
rearrangement occurs. Frequencies for pro-B/pre-B rearrangements far ex-
ceed those from other lineages and stages. Frequencies at various distance
intervals from CpG and CAC, along with comparison to random breakpoint
distributions, are shown in the Supplemental Data (Figure S3). Statistical anal-
ysis of this phenomenon is described in the Experimental Procedures and
Supplemental Experimental Procedures.1134 Cell 135, 1130–1142, December 12, 2008 ª2008 Elsevier Inc.Junctional additions at translocation junctions provide such
a clue. The presence of apparently random nucleotides be-
tween the two breakpoints at a translocation junction is charac-
teristic for the activity of terminal deoxynucleotidyl transferase
(TdT), which is normally expressed only in pro-B/pre-B or
pro-T/pre-T cells and aberrantly in some AMLs. As expected,
bcl-2, bcl-1, LMO2, HOX11, TTG1, and SCL translocations
contain high proportions of junctional additions, whereas
bcl-6 and c-myc translocations contain relatively low propor-
tions (Figure 4A).
The high proportion of junctional additions in E2A-PBX1 trans-
locations indicates that they occur at the pro-B/pre-B stage, as
has been described previously (Wiemels et al., 2002). Addition-
ally, TEL-AML1 and MLL translocations likely occur before the
pro-B stage, prior to TdT and RAG expression, as previously in-
ferred biologically (Castor et al., 2005; Hong et al., 2008; Hotfilder
et al., 2005; Jansen et al., 2007; Pine et al., 2003) (Figure 4). BCR-
ABL translocations in primary ALLs (not ALLs resulting from CML
blast crisis) have been proposed to originate in B cell progeni-
tors, as opposed to the lymphoid-myeloid hematopoietic stem
cell (LM-HSC) origin of BCR-ABL translocations of CMLs (Castor
et al., 2005). Nevertheless, BCR-ABL translocations of primary
ALLs appear to occur prior to expression of TdT and RAGs, as
none of the nine junctions obtained contained nucleotide addi-
tions. On the basis of these analyses, we stage the lymphoid
and myeloid translocations as in Figure 4C.
CpG Hotspots Are Specific to Pro-B/Pre-B Stage
Translocations
Although CpG-type DSBs are prominent in the pro-B/pre-B stage
translocations (i.e., bcl-2, bcl-1, and E2A), no significant CpG
proximity is found in rearrangements at the LM-HSC stage. In
TEL-AML1 translocations, there is no significant CpG proximity
among 53 breakpoints spread across 13 kb of TEL or their part-
ners scattered over 165 kb of AML1. The same is true for break-
points involving the 8.6 kb MLL region in 291 cases of primary
ALL, 24 cases of primary AML, and 35 leukemias secondary to
topoisomerase II-inhibitor treatment. AML1-ETO translocations
show no significant CpG proximity among 67 breakpoints strewn
over 24 kb of AML1 or 66 breakpoints dispersed across 57 kb of
ETO. Philadelphia chromosome t(9;22)(q34;q11) translocations
from CMLs are no different, at either the 35 breakpoints found
in the 2.8 kb major breakpoint cluster region (M-BCR) or the 25
locatable breakpoints stretched over 125 kb of ABL.
No significant CpG proximity is found in mature/activated
B cell translocations. Neither 125 breakpoints in c-myc nor 37
breakpoints in bcl-6 spanning 2 kb are significantly close to
CpG motifs. Interestingly, c-myc and bcl-6 have higher CpG
densities than the bcl-2 MBR and bcl-1 MTC, yet only 17% of
breakpoints occur at CpGs in c-myc and only 19% in bcl-6, com-
pared to 43% for the MBR and 37% for the MTC.
T cell and some pre-B cell rearrangements tend to use a
V(D)J-type rather than a CpG-type mechanism, occurring very
nonrandomly next to CACs (the minimal sequence of the RSS)
rather than CpGs (Table S1, Figure 3, Figure S3). Two hundred
and eight of 209 SCL-SIL breakpoints spanning 89 kb, 35 of 41
lymphoid Dp16 breakpoints spanning 231 kb, all 13 HOX11
breakpoints, and all six TTG-1 breakpoints are compatible with
a typical V(D)J-type breakage mechanism. Dp16s from B-ALLs
behave similarly (Kitagawa et al., 2002). CpGs are often found
in the vicinity of the applicable CACs but are not used as the
site of the breakage.
The 19 SCL breakpoints from SCL-TCR translocations cannot
be confidently assigned to a single breakage type and could be
a mixture that includes random-type breakage. Statistical analy-
Figure 4. Junctional Additions Help Reveal
the Stage of Rearrangement
(A) Stacked proportions of junctions with nucleo-
tide additions, microhomology, or neither are plot-
ted in dark blue, light blue, or light green, respec-
tively, for various translocations. LM-HSC is
lymphoid-myeloid hematopoietic stem cell. Junc-
tions from pro-B/pre-B and pro-T/pre-T rear-
rangements (i.e., bcl-1, bcl-2, E2A-PBX1, SCL-
SIL, and p16 deletions) have a high frequency of
nucleotide additions due to strong expression of
TdT. In contrast, junctions from rearrangements
in other cell stages or types tend to use microho-
mology because the cells in which they occur do
not express TdT. Interestingly, some AMLs with
AML1-ETO translocations aberrantly express low
levels of TdT, which may account for their interme-
diate rate of nucleotide additions. This is signifi-
cant because MLL, TEL-AML1, and BCR-ABL
translocations are seen in pro-B/pre-B stage
ALLs but actually occur at the LM-HSC stage.
bcl-1 and bcl-2 translocations are found in mature
B lymphomas but actually occur at the pro-B/pre-
B stage. E2A translocations are found in pro-B/
pre-B stage ALLs and occur at that stage. These
conclusions are diagrammed in (B) and (C).
(B) When rearrangements are organized by the
stage of the neoplasm in which they are found
(i.e., the tumor’s cell of origin), CpG-type hotspots
do not appear to follow any pattern. Stages of dif-
ferentiation are written in black type and rear-
rangements are written in colored type.
(C) Organizing by the stage of development during
which the rearrangement occurs reveals that CpG-
type hotspots, which occur in the translocations in
green type, only occur in the pro-B/pre-B stage.
sis is ambiguous, being significant for
both CpG and CAC. CAC is more domi-
nant in 31 LMO2 breakpoints, of which
21 are compatible with V(D)J recombina-
tion; however, the remainder could be
other types (CpG plus random breaks).
In summary, CpG-type hotspots do not
appear to occur outside the pro-B/pre-B
stage (Table S1, Figure 3, and Figure S3).
The Widths and Shapes of
CpG-Type Breakpoint Hotspots
Implicate a Structure-Specific
Breakage Mechanism
CpG-type breakpoint clusters differ in
width and shape from V(D)J-type,
CSR-type, and random-type DSBs. In
rearrangements such as BCR-ABL and TEL-AML1, break-
points extend over tens or hundreds of kilobases, and different
leukemias rarely share the same breakpoint. Presumably, the
breakage mechanism is sequence independent and, thus,
any clustering of breakpoints is due to random chance, selec-
tive growth advantage, and/or chromatin accessibility
(Greaves and Wiemels, 2003). Such broad clustering effects,Cell 135, 1130–1142, December 12, 2008 ª2008 Elsevier Inc. 1135
however, do not explain how V(D)J-type and CpG-type rear-
rangements can occur over equally large or larger regions
but strongly prefer small windows and even specific nucleo-
tide positions.
The distributions of V(D)J-type and CpG-type breakpoint
clusters are also very different from one another, suggesting
that they operate by very different mechanisms. V(D)J-type
clusters have a ‘‘spike-and-single-sided tail’’ distribution, be-
cause a site-specific break first occurs 50 to the CAC of the
RSS, followed by limited recessing only into the pseudo-coding
end side of the break (Figures 2D and 2E, Figure S5). However,
CpG-type breakpoint hotspots are more bell-shaped, with
breakpoints on either side of the highest CpG spike; therefore,
initial breakage likely occurs around CpG sites with less preci-
sion than the V(D)J-type (Figure 2A, Figure S5). Heterogeneity
in nick sites is not typical of sequence-specific processes
such as V(D)J recombination or sequence-specific nucleases
such as restriction enzymes; it is, however, consistent with
structure-specific nucleases.
The RAG Endonuclease Is Capable of Nicking One-Base
Mismatches and Processing Nicks, Gaps, and Flaps into
Double-Strand Breaks
In addition to cutting sequence-specifically at an RSS, the RAG
complex is also a structure-specific endonuclease (Raghavan
et al., 2005, 2007; Santagata et al., 1999). Moreover, RAGs are
expressed during the pro-B/pre-B stage, when CpG-type
DSBs occur, and not expressed during the LM-HSC and ma-
ture/activated B cell stages, when CpG-type DSBs do not occur.
Thus, the RAG complex is a natural candidate for involvement in
CpG-type DSBs. We sought to determine the flexibility of the
structure-specific nuclease activity of the RAG complex as it
could relate to CpGs.
In accord with its structure-specific endonuclease activity, we
have previously shown that the RAG complex can nick large
structural deviations such as three- to ten-base bubbles and het-
eroduplexes but not one-base bubbles (Raghavan et al., 2005,
2007). However, after lengthening the oligonucleotide sub-
strates, we find nicking can occur at one-base bubbles (mis-
matches), and nicking efficiency appears to correlate with struc-
tural instability (Figure 5A, Figure S6) (Peyret et al., 1999). The
most unstable mismatches, C:T and C:A, are nicked at about
6% the efficiency of a very strong RSS. The more stable mis-
matches T:T and T:G are nicked about 6-fold less efficiently,
whereas control C:G and T:A duplexes were not detectably
nicked. Although nicking of the T:G mismatch is less efficient
than that at C:T and C:A, it is still quite substantial and greater
than at certain known sites of V(D)J recombination such as
SCL and SIL (Zhang and Swanson, 2008).
The RAG complex also cuts on the antiparallel strand across
from nicks, gaps, and flaps at a rate similar to or higher than
that for unstable mismatches in vitro (Figure 5B). Such activity re-
sults in DSBs. Importantly, the nick, gap, and flap substrates dis-
play a heterogeneous nicking pattern around the lesion, similar
to the pattern of breakpoints seen around CpG at the bcl-2
MBR. Mechanistically, the RAG complex is capable of generat-
ing DSBs in a manner consistent with CpG hotspots.1136 Cell 135, 1130–1142, December 12, 2008 ª2008 Elsevier Inc.DISCUSSION
Mechanistic and Developmental Model for Classifying
Chromosomal Rearrangements and the Role of the CpG
Motif
In vertebrates, CG is a very special dinucleotide because of
methylation of the C5 position of cytosines in the CG context.
Spontaneous deamination of 5-methylcytosine results in thy-
mine, and thus a T:G mismatch. Unmethylated cytosines also
deaminate but result in U:G mismatches (Figure S7). Normally,
both types of lesions are corrected by base-excision repair
(BER). A glycosylase first removes the damaged base, creating
an abasic site. APE1 or spontaneous b-elimination then creates
a single-strand gap, which is filled in by polymerase b, and the
resulting nick is sealed by ligase III:XRCC1 (Friedberg et al.,
2006; Lindahl et al., 1997; Nash et al., 1997). But when DNA rep-
lication occurs before BER can be completed, a polymerase pla-
ces adenine across from the deaminated base, resulting in
a stable point mutation.
T:G mismatches, however, are thought to be more persistent
than U:G mismatches. T:G mismatch processing glycosylases,
thymine DNA glycosylase (TDG), and methyl-CpG binding domain
protein 4 (MBD4), are more than 2500-fold less efficient in vitro
than uracil DNA glycosylase (UDG), which processes U:G
(Schmutte et al., 1995; Walsh and Xu, 2006). As a result, CpG to
TpG transitions account for a disproportionate number of muta-
tions in p53, BRCA1, BRCA2, p16, and Rb across a wide range
of neoplasms (Pfeifer, 2006). Moreover, over evolutionary time,
CG has become statistically underrepresented in vertebrate ge-
nomes but is preserved in small and functionally important regions
around promoters termed CpG islands (Antequera et al., 1990;
Bestor, 2003; Bird, 1992; Takaiand Jones,2003; Yangetal., 1996).
Persistent T:G mismatches, per se, do not lead to DSBs. How-
ever, as demonstrated above, the RAG endonuclease could act
at the T:G mismatch and/or the vulnerable nick and gap interme-
diates during the BER process. Direct nicking of the T:G mis-
match would result in flap-mismatch lesions, which, unlike nor-
mal V(D)J-type nicks at CACs, would not be religated readily
by ligase I because of the mismatch at the point of ligation (Tom-
kinson et al., 2006). Alternatively, a one-base gap could first be
generated from normal processing by TDG or MBD4 and APE.
A subsequent RAG nick across from such a nick or gap would
then result in a DSB. We observe that these nick sites are hetero-
geneous rather than site specific in vitro, consistent with the het-
erogeneity in patient breakpoints at CpG hotspots. Involvement
of the RAG complex would therefore explain two key aspects of
CpG hotspots: (1) why CpG-type rearrangements only occur at
the pro-B/pre-B stage during which the RAG complex is ex-
pressed and (2) why the distribution of CpG-type hotspots is het-
erogeneous around CpGs (Figures 3 and 6 and Figure S5).
However, T cells also express RAGs but do not appear to have
CpG-type rearrangements. One way to account for this may be
the recent finding of activation-induced deaminase (AID) expres-
sion in early B cells (Crouch et al., 2007; Feldhahn et al., 2007;
Mao et al., 2004), in addition to its established pattern of expres-
sion in mature activated B cells (and its known absence from
T cells). AID in early B cells is consistent with previous work
showing that pre-B cell lines can undergo class switch
recombination (Alt et al., 1982; Burrows et al., 1983). AID deam-
inates cytosines in single-stranded DNA in mature B cells during
class switch recombination (at R loops) and somatic hypermuta-
tion (Di Noia and Neuberger, 2007). Lower but still significant
rates of deamination exist for genomic regions which are outside
of the Ig loci, such as c-myc and bcl-6 (Liu et al., 2008). Impor-
tantly, AID can act on methylated cytosines (Bransteitter et al.,
2003; Morgan et al., 2004). Therefore, involvement of AID would
explain why CpG-type rearrangements only occur in the B cell
lineage, and its cytosine deamination activity is exactly the
same as the basis for enrichment of point mutations at CpGs
in cancers and CpG suppression.
Figure 5. The Structure-Specific Endonuclease Activity of the RAG Complex at Mismatches
(A) The structure-specific endonuclease activity of the RAG complex at one-base mismatches is shown. RAGs nick one-base bubbles having arms of 31 bp and
38 bp and lacking CAC at a low level (black brackets on gel and filled triangles on left-hand diagrams). Fully duplex DNA is not visibly nicked, and a good 12 signal
is nicked efficiently. Lanes without RAGs were incubated with HMGB1 alone and do not show nicking. The diagrammed structure on the lower left margin of the
gel depicts (expected) RAG nicking on the wrong side of the heptamer adjacent to the spacer.
(B) The structure-specific endonuclease activity of the RAG complex is shown at nicks, gaps, and flaps, which are cut at a similar level or higher (relative to the
mismatches in [A]) and at heterogeneous positions around the lesion. The 12 signal and duplex DNA controls are similar to those in (A). The diagrammed struc-
tures on the right margin depict the two alternative flap configurations that result after annealing the flap oligonucleotides.Cell 135, 1130–1142, December 12, 2008 ª2008 Elsevier Inc. 1137
On the basis of this evidence, we propose the lesion-specific
DSB mechanism diagrammed in Figure 6. A low level of AID
expression in early B cells leads to an increased rate of cytosine
deaminations, which are adequately repaired at unmethylated
cytosines but persist at methylated cytosines as T:G mis-
matches. These sites are then converted to DSBs by RAGs,
before or during attempted repair by T:G mismatch repair en-
zymes. The resulting DNA ends join to ends from a V(D)J recom-
bination or other double-strand break event and lead to the chro-
mosomal translocations observed so frequently in human B cell
lymphomas.
Mice as Models for Human Lymphomas
For the most part, mice do not develop lymphomas and leuke-
mias in the same way as humans. In the United States, human
lymphomas are overwhelmingly of B cell origin, tend to occur
in older individuals, and most contain clonal translocations (Jaffe
et al., 2001; Wada et al., 1993). By contrast, lymphomas in mice,
including p53/ and p53+/ mice, are mostly of T cell origin and
lack clonal translocations (Bassing et al., 2008; Liao et al., 1998).
The one exception is mouse plasmacytomas with t(12;15)
c-myc-IgH translocations induced by pristane and IL-6 (Di Noia
and Neuberger, 2007; Muller et al., 1995). The equivalent in
Figure 6. Theoretical Mechanism for CpG-Type Double-Strand
Breakage
Deamination at a methylcytosine within a CpG creates a T:G mismatch that
persists because of catalytic inefficiency of methyl-CpG binding domain pro-
tein 4 (MBD4) and thymine DNA glycosylase (TDG) in cleaving the thymine gly-
cosidic bond, leaving an abasic site (+). Single-strand breaks are generated
either by the normal base excision repair pathway of glycosylase and AP en-
donuclease (APE) activity or by RAG nicking the mismatch directly, resulting
in a poorly ligatable flap. Heterogeneous RAG nicking of the remaining strand
creates a double-strand break close to the original site of the T:G mismatch.
Nicking by the RAG complex at one-base mismatches and across from nicks,
gaps, and flaps is experimentally shown in Figure 5. Nucleolytic resection of
the ends before aberrant joining results in a breakpoint distribution similar to
that seen in Figure 2. We observe the following features at CpG-type translo-
cation hotspots: (1) an extremely high degree of focusing to CpGs, (2) a break-
point distribution consistent with a structure-specific endonuclease, (3) spec-
ificity to the pro-B/pre-B stage, and (4) specificity to the B cell lineage.
Involvement of the RAG complex explains points 2 and 3, while involvement
of AID explains point 4 and is strongly suggestive for point 1.1138 Cell 135, 1130–1142, December 12, 2008 ª2008 Elsevier Inc.humans is the t(8;14) described previously, which occurs at the
mature/activated B cell stage and not the pro-B/pre-B stage of
interest.
The observed incongruency between mouse and human lym-
phomagenesis may be explained in several ways. First, point
mutations of critical genes are sufficient to drive T cell lympho-
magenesis at early ages in mice, masking slower-developing
tumors. Experimental demonstration for this comes from a study
in which mice constitutively expressing c-myc developed only
T cell lymphomas, whereas RAG1 knockouts constitutively
expressing c-myc developed a range of hematological malig-
nancies, including B-LBLs, pre-T cell lymphomas, myeloid pro-
genitor tumors, and cutaneous macrophage tumors (Smith
et al., 2005).
Second, translocations and even oncogene overexpression
often have no effect on mouse lymphomagenesis. Mice with ge-
nome-wide instability, such as H2AX/, develop many different
translocations but do not develop tumors (Bassing et al., 2008).
Overexpression of the bcl-2 or bcl-1 oncogenes in mice can
cause hyperplasia but does not lead to lymphoma (Lovec
et al., 1994; McDonnell et al., 1989). Even asymptomatic humans
can harbor B cells with t(14;18) translocations (Liu et al., 1994),
suggesting that additional mutations may be required to drive
these translocation-bearing B cells to malignancy.
Third, few mouse models are checked past 1 year. It may be of
some value to follow mice into older ages in an attempt to detect
slower-developing tumors. However, even calorie-restricted
mice do not live past 3 years, which may still be simply too short
in comparison to human lymphomas which develop in the fifth or
sixth decades of life.
Mice as Models for CpG-Type Translocations
According to the proposed mechanism, AID-overexpressing
mice should have increased rates of translocation in both the
B and T lineages. Similarly, RAG-overexpressing, MBD4 knock-
out, UNG knockout, and MSH2 knockout mice should develop
more translocations in germinal center B cells.
AID overexpressors developed only T cell lymphomas with no
clonal translocations (Okazaki et al., 2003). As described above,
point mutations may be driving lymphomas in these mice and
masking latent tumors.
Mouse B cell follicular lymphomas arose in UNG/ mice after
12 months, but these were not characterized for translocations
(Nilsen et al., 2003). MSH2/ mice developed B and T lympho-
blastic lymphomas, and these were not examined for transloca-
tions either (Reitmair et al., 1995). It may be valuable to assess
them for translocations, though it would not be surprising if
AID-induced p53 mutations or c-myc-IgH translocation events
were driving these lymphomas. MBD4 knockout mice are not
especially susceptible to tumors (Wong et al., 2002). RAG1/2-
overexpressing mice are small and die early (Barreto et al., 2001).
Thus, CpG-type translocations, as they occur in humans, are
not observed in existing mouse models. Part of the problem
may be that most studies focus on lymphomagenesis and that,
with the exception of c-myc, translocations in mice typically do
not cause lymphomas. More sensitive assays, such as high-
throughput methods, may be required to detect any increases
in low-frequency translocations events.
Implications and Testable Predictions
If the theory is correct, it has some intriguing implications. First,
individuals whose pro-B/pre-B cells have higher AID activity
would be more susceptible to these rearrangements. Second,
individuals with SNPs at CpGs within the MBR and MTC, as
well as individuals whose pro-B/pre-B cells are unmethylated
at those CpGs, would be less susceptible to these rearrange-
ments than individuals in which those CpGs are methylated.
However, it is important to note that removal of any single CpG
would result in only a small drop in DNA breakage in the MBR
and MTC. The model predicts that individuals with SNPs at spe-
cific CpGs would not have chromosomal translocations at those
SNP sites. The emerging affordability of high-throughput se-
quencing may allow one to investigate whether the normal pro-
B/pre-B cells in patients with such lymphomas have higher levels
of AID activity and/or DNA methylation at the breakpoint cluster
regions.
There are a multitude of approaches one may take to test the
theory by conventional experimental means. The main problem
seems to be the exceedingly low frequency of deamination
events and rearrangement events. Without accounting for repair,
the frequency of spontaneous hydrolytic deamination of cyti-
dines in duplex DNA is on the order of 106 per cytosine over
14 days (Frederico et al., 1990). In mice, the highest reported
rate of AID-catalyzed mutation at non-V(D)J loci was about
0.1% per base in mature/activated B cells (Liu et al., 2008;
Mao et al., 2004). However, with high-throughput sequencing,
AID-induced increases in C to T mutations at CpG sites may
be detectable.
As mentioned above, B cell lymphomas arising in UNG/ or
MSH2/ mice may be worth analyzing for chromosomal trans-
locations (Nilsen et al., 2003; Reitmair et al., 1995). With high-
throughput sequencing, mutated CpG sites could be analyzed
for evidence of double-strand breaks in the form of small dele-
tions and additions, indicative of DSBs that were repaired by
nonhomologous DNA end joining.
Basis for Translocation Clustering and the Relationship
to Translocation Hotspots
The proposed mechanism also has implications for the long-
standing mystery of why the translocations cluster in the first
place—that is, why they occur so frequently at CpGs within the
MBR and MTC, as opposed to distributing across all the other
CpGs in the surrounding tens or hundreds of kilobases. The
very same problem is seen for CACs in V(D)J-type rearrange-
ment clusters, where breakpoints occur at only a fraction of
the available CACs, and not the ones predicted by experimental
systems (Marculescu et al., 2002; Raghavan et al., 2001; Zhang
and Swanson, 2008). As far as clustering with CpG-type hot-
spots, possible explanations can be grouped into those that pro-
mote breakage and recombination (such as increased methyla-
tion, selective AID or targeting of the RAG complex, slow repair
rate, chromosomal positioning, and failure to sequester free
ends at certain loci) and those that prevent recombination events
from appearing in cancers (such as lack of a growth advantage).
As the other possibilities are discussed elsewhere, only the first
two will be discussed below.Though unlikely, the most obvious explanation would be se-
lective hypermethylation within the MBR and MTC. Methylation
analysis of the MBR and MTC showed considerable variation
within and between FACS-sorted pre-B cells from five healthy in-
dividuals of similar age. CpGs outside the clusters were methyl-
ated at the same or higher rate (Figure S8). Hence, although there
are plenty of methylated CpG targets for deamination-based
translocations, selective hypermethylation does not appear to
explain targeting to the MBR or MTC—at least to the extent
that our samples are similar to those that develop into lymphoma
(Figure 4A).
Hydrolytic deamination of methylcytosine is extremely slow in
duplex DNA but is accelerated 500- to 1000-fold when the base
is unpaired or single stranded (Frederico et al., 1990). Moreover,
AID is much more active on unpaired cytosines than on base-
paired cytosines (Bransteitter et al., 2003; Di Noia and Neu-
berger, 2007; Pham et al., 2003; Yu et al., 2004). Therefore,
one would expect CpGs in single-stranded regions to be more
susceptible to deamination. We have previously shown that the
bcl-2 MBR reacts with the single-strand-specific chemical probe
bisulfite, suggesting some degree of single-stranded character
inherent to the DNA in this region (Raghavan et al., 2004). The
centromeric end of the 150 bp bcl-1 MTC also shows a high de-
gree of bisulfite reactivity (A.G.T. and M.R.L., unpublished data).
This naturally leads to the hypothesis that AID may target cyto-
sines within these regions because of their increased propensity
for single strandedness.
Single-stranded character may also be caused by slippage at
repeat sequences, induced by a passing RNA or DNA polymer-
ase. Such a mechanism has been suggested on the basis of se-
quence data from a yeast LYS2 reporter system (Kim et al.,
2007). AID is more active on small bubble structures (such as
3 bp to 7 bp) than on larger bubble structures and more active
on supercoiled DNA than nicked circular DNA (Larijani and
Martin, 2007; Shen and Storb, 2004). Therefore, even slight per-
turbations in the DNA can significantly enhance AID action. At
the bcl-2 mcr, there is an 8 bp direct repeat on each side of
one CpG hotspot. A slippage event between the top and bottom
strand would place the CpG within a loop, thereby making it vul-
nerable to hydrolytic deamination or to AID.
In summary, we have analyzed over 1700 human chromo-
somal rearrangement breakpoints grouped according tissue
type, lineage, and developmental stage. On the basis of this,
we have identified a new type of double-strand breakage motif,
which appears to shape the breakpoint distributions within the
bcl-2 MBR, bcl-2 icr, bcl-2 mcr, bcl-1 MTC, and E2A cluster re-
gions. This CpG-type breakage is prominent in pro-B/pre-B cells
and apparently absent or heavily diminished in other cell types.
We propose that deaminated methyl-CpGs within cluster re-
gions are intercepted by RAGs before repair can be completed,
generating the requisite double-strand breaks in several of the
most common translocations in human lymphoma.
EXPERIMENTAL PROCEDURES
Statistical Analysis
Junctions and breakpoints were obtained from literature and GenBank
searches and aligned with hg18 from the UCSC genome browser (KentCell 135, 1130–1142, December 12, 2008 ª2008 Elsevier Inc. 1139
et al., 2002) with BLAT (Kent, 2002) and verified by eye. A breakpoint ‘‘at’’
a CpG is defined as being either 50 to the C, between the C and G, or 30 to
the G, i.e., ;CG, C;G, or CG;. For binomial probabilities, the random proba-
bility p is calculated as the number of sites at motifs divided by the total num-
ber of sites from the most 50 to the most 30 breakpoint. ‘‘Distance’’ to a motif is
calculated as the number of nucleotides between the breakpoint and the clos-
est motif site. Distance distributions for uniformly or ‘‘randomly’’ distributed
breakpoints were generated by traversing the region from the most 50 to the
most 30 breakpoint, treating each strand independently, and calculating the
distance to the closest motif for each site along the way. These distributions
were used for a Student’s t test with a standard Box-Cox log(x + 1) transforma-
tion to correct for nonnormality, and for a Mann-Whitney U test. t and z values
were converted to p values in Excel. Details of this analysis are discussed in the
Supplemental Experimental Procedures. The database of annotated break-
points and junctions will be available online in computer-readable format.
RAG Endonuclease Assays
Substrates were prepared by boiling PAGE-purified, 50-labeled oligonucleo-
tide with 1.5-fold excess PAGE-purified cold oligonucleotide(s) and slow cool-
ing. Protein purification and assay were as described previously (Raghavan
et al., 2007) (see the Supplemental Experimental Procedures).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Introduction, Supplemental Results,
Supplemental Experimental Procedures, eight figures, and one table and
can be found with this article online at http://www.cell.com/supplemental/
S0092-8674(08)01372-X.
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